PharmaForceIQ
PharmaForceIQ is an AI-powered optichannel customer engagement platform for pharmaceutical and biotech companies, unifying brand and field strategy through real-time HCP affinity data, AI-driven Next-Best-Action recommendations, and deployment across 75,000+ digital and field channels.
- Company typePrivate
- Founded2020
- HeadquartersHingham, United States
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What PharmaForceIQ does
PharmaForceIQ is a US-based, private enterprise SaaS company founded in 2020 that provides an AI-powered optichannel customer engagement platform for pharmaceutical and biotech commercial teams. The platform unifies brand and field strategy through a combination of proprietary affinity data on 7M+ healthcare professionals (HCPs), AI-driven Next-Best-Action (NBA) recommendations, and real-time orchestration across field, digital, and peer-to-peer channels. Content is deployed within 24-48 hours of clinical or behavioral signal detection across 75,000+ digital sites and platforms, with native integrations into Veeva CRM, Medscape NBE, EHR data, and medical/script claims vendors.
Following the January 2026 asset acquisition of Aktana, PharmaForceIQ combined its digital orchestration platform with Aktana's AI-driven field NBA capabilities, creating an end-to-end optichannel-in-a-box solution. The integrated stack incorporates Aktana's Knowledge Nexus dataset (built on 100M+ field suggestions and 5,000+ tactics executed over twelve years) and the TacticGenie AI journey planner. The company serves pharmaceutical and biotech clients across oncology, rare disease, and other therapeutic areas, with named or referenced customers including Day One Biopharmaceuticals, Merck (Medical Affairs), and Merus, plus multiple anonymized large-pharma enterprise engagements.
PharmaForceIQ operates on a flat-fee enterprise subscription model that bundles technology, data, and media contracting, distinguishing it from traditional agency commission structures. The company received a majority investment from healthcare-focused PE firm Eir Partners in September 2024 and has subsequently expanded its geographic footprint across the United States, LATAM, APAC, and EMEA. The company holds ISO 27001, SOC 2 Type II, HIPAA, HITECH, CCPA, and NAI certifications, supporting its position with regulated pharma buyers and creating procurement-grade compliance baselines.
PharmaForceIQ firmographics
Firmographics- Name
- PharmaForceIQ
- Legal name
- PharmaForceIQ
- Website
- https://pharmaforceiq.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- PharmaForceIQ is an AI-powered optichannel customer engagement platform for pharmaceutical and biotech companies, unifying brand and field strategy through real-time HCP affinity data, AI-driven Next-Best-Action recommendations, and deployment across 75,000+ digital and field channels.
- Ownership category
- akta.pro rank
PharmaForceIQ industry classification
Industry- Product category
- Pharmaceutical Marketing Software
- NAICS
- Software Publishers (5132)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Model Serving, Inference & Deployment Platforms (APIs, Edge/On-Prem) (HDAEANAC)
Keywords
Where PharmaForceIQ is headquartered
LocationHeadquarters
- HQ city
- Hingham
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
PharmaForceIQ business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations
Revenue model
- Platform Subscription and Licensing: Enterprise SaaS platform providing end-to-end customer engagement capabilities. The company charges a flat fee that includes technology, data, and media contracting. The model incentivizes efficiency rather than higher spend, differentiating from traditional agency commission models that incentivize higher budgets.
- Professional Services and Implementation: Strategic partnership and implementation services to deploy the optichannel-in-a-box solution. Deployable in 6-8 weeks.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
PharmaForceIQ product offering
Product offeringCore offering
PharmaForceIQ sells an AI-powered "optichannel-in-a-box" customer engagement platform for pharmaceutical and biotech companies that unifies brand and field strategy in real time. The platform deploys personalized content across field, digital, and peer-to-peer channels based on clinical and behavioral signals, with deployment speeds of 24-48 hours and reach across 75,000+ digital sites plus a proprietary database of 7M+ HCP profiles. Following the January 2026 acquisition of Aktana, the offering now also bundles AI-driven field Next-Best-Action recommendations powered by Aktana's Knowledge Nexus dataset.
Product overview
PharmaForceIQ offers a unified optichannel customer engagement platform for life sciences, combining a core orchestration platform with modular AI-powered components. The platform integrates the company's proprietary Affinity Intelligence (7M+ HCP profiles), Real-Time Analytics Dashboard, and deployment across 75,000+ digital channels with Aktana's Field Next-Best-Action capabilities (including Knowledge Nexus dataset and TacticGenie AI journey planner) to deliver the industry's first end-to-end 'optichannel-in-a-box' solution. The integrated system unifies brand and field strategy, powers Next-Best-Action recommendations for sales reps, and deploys personalized content within 24 hours of clinical triggers. PharmaForceIQ offers specialized solutions for Commercial Leaders, HCP Marketers, DTC Marketers, Omnichannel Leaders, Medical Affairs, and Sales Leadership teams.
Differentiator
Problem solved
Functional benefit
Products and services
- PharmaForceIQ Optichannel Platform An end-to-end real-time customer engagement platform that unifies brand and field strategy for pharmaceutical commercial teams, using AI-powered optichannel marketing to engage healthcare professionals and patients across optimal channels with personalized content deployed within 24 hours of triggers.
- Aktana Field Next-Best-Action Platform AI-driven field orchestration platform providing Next-Best-Action recommendations to pharmaceutical sales reps, powered by Aktana's proprietary Knowledge Nexus dataset built on over 100 million field suggestions and 5,000+ tactics executed over twelve years. Now integrated into the PharmaForceIQ platform.
Quantifiable outcome
- 3x average script lift
- +10 more outcomes
Companies that use PharmaForceIQ
Customer profileNamed customers8 records
Segments6 records
Ideal customer profiles3 records
PharmaForceIQ technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration5 records
AI capability9 records
Feature5 records
PharmaForceIQ partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and minor.
- AktanacorePharmaForceIQ acquired Aktana in an asset purchase combining its digital orchestration platform with Aktana's AI-driven field Next-Best-Action capabilities. This creates the industry's first 'optichannel-in-a-box' commercial engagement system. Aktana's Knowledge Nexus dataset contains insights from 100M+ field suggestions and 5,000+ tactics over twelve years. Derek Choy, former Co-Founder and CPO of Aktana, joined as PharmaForceIQ's Head of Product.
- MedscapeminorMedscape's Next Best Engagement (NBE) program is one of the high-performing channels in PharmaForceIQ's platform. Medscape accounted for approximately 45% of all engagements in the first 12 months of one campaign and was identified as the highest performing platform among third-party partners.
Scale indicators7 records
Recent moves6 records
Expansion highlights6 records
PharmaForceIQ competitors and assessment
Company assessmentBroad incumbents
- Ogilvy Health: Ogilvy Health (WPP Health Practice) is a global pharma/health creative and engagement agency. While primarily services-led rather than platform-led, it competes for the same commercial-leader budget that PFIQ targets with its optichannel-in-a-box proposition.
- IQVIA: IQVIA offers Orchestrated Customer Engagement (OCE) and a broad portfolio of pharma commercial analytics, RWD, and sales force effectiveness tools. It is a broader incumbent serving many of the same pharma commercial leaders PFIQ targets, but as part of a vast life-sciences services platform.
- EVERSANA: EVERSANA is a large pharma commercialization services provider (sales, marketing, data, distribution) that increasingly offers AI-enabled engagement technology. It is an incumbent that competes broadly across pharma commercial workflows PFIQ addresses.
Direct peers
- OptimizeRx: OptimizeRx operates a point-of-care/HCP engagement platform that reaches prescribers through EHR workflows and delivers real-time messaging during clinical decision moments. It directly competes with PFIQ in the HCP-trigger-based, signal-driven engagement category, especially for non-personal promotion.
- Veeva Systems: Veeva is the dominant enterprise SaaS platform for pharma commercial operations, including Veeva CRM (field sales) and PromoMats. PFIQ integrates with Veeva CRM to deploy NBA suggestions into rep workflows, making Veeva a direct competitor on field orchestration and the most relevant benchmark for pharma commercial SaaS.
- Real Chemistry: Real Chemistry (formerly W2O Group) is an AI-driven healthcare marketing agency with integrated health intelligence data, audience targeting, and content orchestration. They compete for the same commercial-leader budget that PFIQ targets, with comparable client rosters among top-20 pharma.
- DeepIntent: DeepIntent is a programmatic advertising platform purpose-built for pharma, with HCP and DTC activation, identity resolution, and measurement. It competes for the same digital pharma media and engagement budget that PFIQ's Orchestration Engine executes against.
- ZS Associates: ZS runs the Affinity portfolio (AffinityMonitor, AffinityMap, AffinityLive, AffinityEngage) providing pharma HCP audience intelligence and field/digital orchestration. ZS is the most direct functional analog to PFIQ's Affinity Intelligence + orchestration stack, serving the same pharma commercial buyers.
- Indegene: Indegene is a digital-first commercial services and technology provider for life sciences, offering omnichannel HCP/patient engagement, medical affairs, and content platforms. It competes directly with PFIQ for marketing-tech and omnichannel budgets inside pharma and biotech.
- Intouch Group / VMLY&R Health: Intouch Group is a pharma-focused digital marketing agency with proprietary AI and analytics offerings (e.g., AI Media Planning), directly serving HCP and DTC marketing needs PFIQ's solutions address.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat6 records
Key risks5 records
Key highlights6 records
Customer concentration
PharmaForceIQ social profiles
Digital presencePharmaForceIQ compliance and trust
Trust signalCompliance6 records
PharmaForceIQ financial estimates
Financial estimateRevenue estimate
Valuation estimate
PharmaForceIQ leadership team
Management profileNumber of profiles
Profiles5 records
PharmaForceIQ subsidiaries and ownership
Company hierarchySubsidiaries1 record
PharmaForceIQ funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PharmaForceIQ M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PharmaForceIQ
What does PharmaForceIQ do?
PharmaForceIQ sells an AI-powered "optichannel-in-a-box" customer engagement platform for pharmaceutical and biotech companies that unifies brand and field strategy in real time. The platform deploys personalized content across field, digital, and peer-to-peer channels based on clinical and behavioral signals, with deployment speeds of 24-48 hours and reach across 75,000+ digital sites plus a proprietary database of 7M+ HCP profiles. Following the January 2026 acquisition of Aktana, the offering now also bundles AI-driven field Next-Best-Action recommendations powered by Aktana's Knowledge Nexus dataset.
Is PharmaForceIQ a public or private company?
PharmaForceIQ is a private company. It is classified as private equity controlled and is currently operating.
When was PharmaForceIQ founded?
PharmaForceIQ was founded in 2020. It employs 51 to 100 people.
Where is PharmaForceIQ based?
PharmaForceIQ is headquartered in Hingham, United States, in the North America region.
How does PharmaForceIQ make money?
Two revenue lines are on record. Platform Subscription and Licensing is the primary driver. The others are professional Services and Implementation.
Who are PharmaForceIQ's main competitors?
Broad incumbents on record are Ogilvy Health, IQVIA and EVERSANA. Direct peers are OptimizeRx, Veeva Systems, Real Chemistry, DeepIntent, ZS Associates, Indegene and Intouch Group / VMLY&R Health.
Does PharmaForceIQ have an API?
No public API is recorded for PharmaForceIQ.
What industry is PharmaForceIQ in?
PharmaForceIQ's product category is Pharmaceutical Marketing Software. Its primary akta.pro industry code is HDAEANAC, Model Serving, Inference & Deployment Platforms (APIs, Edge/On-Prem). Its NAICS code is 5132 and its SIC code is 7372.